Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation

Detalles Bibliográficos
Autores principales: Treis, Diana, Umapathy, Ganesh, Fransson, Susanne, Guan, Jikui, Mendoza-García, Patricia, Siaw, Joachim T., Wessman, Sandra, Gordon Murkes, Lena, Stenman, Jakob J. E., Djos, Anna, Elfman, Lotta H. M., Johnsen, John Inge, Hallberg, Bengt, Palmer, Ruth H., Martinsson, Tommy, Kogner, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830523/
https://www.ncbi.nlm.nih.gov/pubmed/35085006
http://dx.doi.org/10.1200/PO.21.00271
Descripción
Sumario:

Ejemplares similares